CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sirtex Medical Limited Company Snapshot
Sirtex Medical Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sirtex Medical Limited with three other miscellaneous service companies in Australasia: Pharmaxis Ltd (2017 sales of 17.64 million Australian Dollars [US$13.91 million] of which 77% was Bronchitol and Aridol), Xrf Scientific Ltd (21.54 million Australian Dollars [US$16.99 million] of which 40% was Precious Metals), and Bionomics Limited (18.61 million Australian Dollars [US$14.67 million] of which 88% was Drug discovery and development).

Sales Analysis. During the year ended June of 2017, sales at Sirtex Medical Limited were A$234.28 million (US$184.76 million). This is a very small increase of 0.8% versus 2016, when the company's sales were A$232.49 million. This was the fifth consecutive year of sales increases at Sirtex Medical Limited (and since 2012, sales have increased a total of 184%). Sales of Emea saw an increase that was more than double the company's growth rate: sales were up 419.7% in 2017, from A$38.93 million to A$202.30 million. Sirtex Medical Limited also saw significant increases in sales in Americas (up 1.0% to A$201.03 million) and Unallocated (up 18.7% to A$2.65 million) . Not all segments of Sirtex Medical Limited experienced an increase in sales in 2017: sales of Asia Pacific fell 89.6% to A$17.91 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sirtex Medical Limited
  Stock Performance Chart for Sirtex Medical Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 15.13
(Figures in Australian Dollars)
1 Week 2.8%   13 Weeks 4.9%  
4 Weeks -7.6%   52 Weeks -48.9%  
 
Sirtex Medical Limited Key Data:
  Ticker: SRX Country: Australia
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 234,282,000
(Year Ending Jan 2018).
Employees: 292
  Currency: Australian Dollars Market Cap: 869,446,388
  Fiscal Yr Ends: June Shares Outstanding: 57,465,062
  Share Type: Ordinary Closely Held Shares: 2,000,450
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.